Potok O, Rifkin D, Ix J, Shlipak M, Satish A, Schneider A
Kidney Med. 2023; 5(5):100628.
PMID: 37168389
PMC: 10165149.
DOI: 10.1016/j.xkme.2023.100628.
Keddis M, Howard M, Galapia L, Barreto E, Zhang N, Butterfield R
Nephrol Dial Transplant. 2023; 38(8):1898-1906.
PMID: 36646435
PMC: 10387404.
DOI: 10.1093/ndt/gfad007.
Ge J, Zeng J, Ma H, Sun S, Zhao Z, Jing Y
Nutrients. 2022; 14(23).
PMID: 36501049
PMC: 9738634.
DOI: 10.3390/nu14235020.
Potok O, Ix J, Shlipak M, Bansal N, Katz R, Kritchevsky S
Kidney Med. 2022; 4(3):100416.
PMID: 35386603
PMC: 8978136.
DOI: 10.1016/j.xkme.2022.100416.
Wang Y, Levey A, Inker L, Jessani S, Bux R, Samad Z
Kidney Int Rep. 2021; 6(4):962-975.
PMID: 33912746
PMC: 8071622.
DOI: 10.1016/j.ekir.2021.01.005.
The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
Potok O, Ix J, Shlipak M, Katz R, Hawfield A, Rocco M
Am J Kidney Dis. 2020; 76(6):765-774.
PMID: 32682697
PMC: 8896529.
DOI: 10.1053/j.ajkd.2020.05.017.
Measured glomerular filtration rate does not improve prediction of mortality by cystatin C and creatinine.
Sundin P, Sjostrom P, Jones I, Olsson L, Udumyan R, Grubb A
Nephrol Dial Transplant. 2017; 32(4):663-670.
PMID: 28340079
PMC: 6433429.
DOI: 10.1093/ndt/gfx004.
Effect of remote ischemic preconditioning on postoperative acute kidney injury among patients undergoing cardiac and vascular interventions: a meta-analysis.
Li B, Lang X, Cao L, Wang Y, Lu Y, Feng S
J Nephrol. 2016; 30(1):19-33.
PMID: 27091767
PMC: 5316401.
DOI: 10.1007/s40620-016-0301-x.
Improved early risk stratification with cystatin C-based estimated GFR.
Pavkov M, Nelson R
Am J Kidney Dis. 2014; 63(5):745-8.
PMID: 24602780
PMC: 6380357.
DOI: 10.1053/j.ajkd.2014.02.006.
Comparison of serum cystatin C, serum creatinine, measured GFR, and estimated GFR to assess the risk of kidney failure in American Indians with diabetic nephropathy.
Pavkov M, Knowler W, Hanson R, Williams D, Lemley K, Myers B
Am J Kidney Dis. 2013; 62(1):33-41.
PMID: 23347458
PMC: 3664248.
DOI: 10.1053/j.ajkd.2012.11.044.
Serum cystatin C as a predictor for cardiovascular events in end-stage renal disease patients at the initiation of dialysis.
Shin M, Song S, Kwak I, Lee S, Lee D, Seong E
Clin Exp Nephrol. 2012; 16(3):456-63.
PMID: 22278599
DOI: 10.1007/s10157-011-0583-1.
